Department of Otorhinolaryngology, Head and Neck Surgery, and Audiology, Rigshospitalet, Copenhagen, Denmark.
epartment of Pathology, Rigshospitalet, Copenhagen, Denmark.
Otolaryngol Head Neck Surg. 2023 Aug;169(2):276-285. doi: 10.1177/01945998221123927. Epub 2023 Jan 29.
To investigate thresholds for lymph node yield (LNY), lymph node density (LND), and pN in patients with oral squamous cell carcinoma in relation to previous findings in the literature.
Retrospective register-based study.
Copenhagen Oral Cavity Squamous Cell Carcinoma database.
Appropriate thresholds for LNY, LND, and pN were determined by areas under the curve and subsequently subjected to multivariate analysis. Five-year overall survival and 3-year recurrence-free survival were determined by Kaplan-Meier survival curves.
In total, 413 patients diagnosed with oral squamous cell carcinoma were included. In the pN0 cohort, no superior/prognostic LNY cutoff values were detected. In the pN+ cohort, areas under the curve determined thresholds of LNY, LND, and pN to be 21 nodes, 5%, and 3 metastases, respectively. The 5-year overall survival was 52% for patients with LNY ≥21 vs 38% for patients with LNY <21 (hazard ratio [HR], 1.49; 95% CI, 1.05-2.11; P < .05), 60% for patients with LND ≤5% vs 38% for patients with LND >6% (HR, 1.63; 95% CI, 1.03-2.57; P < .05), and 43% for patients with pN <3 vs 26% for patients with pN ≥3 (HR, 1.40; 95% CI, 1.04-2.15; P < .05).
Increased nodal yield, decreased LND, and decreasing number of pN were associated with significantly improved survival outcomes. LNY might serve as a prognosticator of survival as well as a surgical quality indicator. LND may have implications as a tool in cancer staging and treatment planning.
探讨与文献中先前发现相关的口腔鳞状细胞癌患者的淋巴结检出率(LNY)、淋巴结密度(LND)和 pN 的阈值。
回顾性基于注册的研究。
哥本哈根口腔鳞状细胞癌数据库。
通过曲线下面积确定适当的 LNY、LND 和 pN 阈值,然后进行多变量分析。通过 Kaplan-Meier 生存曲线确定 5 年总生存率和 3 年无复发生存率。
共纳入 413 例口腔鳞状细胞癌患者。在 pN0 队列中,未检测到更优/预后的 LNY 截止值。在 pN+队列中,曲线下面积确定的 LNY、LND 和 pN 的阈值分别为 21 个淋巴结、5%和 3 个转移灶。LNY≥21 的患者 5 年总生存率为 52%,而 LNY<21 的患者为 38%(风险比 [HR],1.49;95%CI,1.05-2.11;P<.05),LND≤5%的患者 60%,而 LND>6%的患者为 38%(HR,1.63;95%CI,1.03-2.57;P<.05),pN<3 的患者 43%,而 pN≥3 的患者为 26%(HR,1.40;95%CI,1.04-2.15;P<.05)。
淋巴结检出率增加、LND 降低和 pN 数量减少与生存结果显著改善相关。LNY 可能既是生存预后的预测因子,也是手术质量的指标。LND 可能作为癌症分期和治疗计划的工具具有一定意义。